Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Piramal looks for 20% RoI from investment in Vodafone India but not mHealth tie-up yet

This article was originally published in Scrip

Executive Summary

Piramal Healthcare has acquired an additional 5.5% in Vodafone India from ETHL Communications Holdings (Essar) for about $600 million, as part of ongoing efforts to park funds in high-growth areas that offer better returns for the short and medium term. According to the pharma company, the move is a strictly financial venture from which it is hoping for up to a 20% return on investment, rather than a strategic move towards the application of mobile communications and network technologies for healthcare, or mHealth.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts